Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02751359Phase 2Completed
Phase 2, randomised, double-blind trial in pain comparing Active CBD with Placebo (2 arms). Primary endpoint: Change From Baseline in Pain Tolerance and Threshold. Started Jul 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02751359.